Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients



Seibel, NL, Shad, AT, Bekersky, I, Groll, AH, Gonzalez, C, Wood, LV, Jarosinski, P, Buell, D, Hope, WW ORCID: 0000-0001-6187-878X and Walsh, TJ
(2017) Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (2).

[img] Text
LAMB-PEDSPK_MS_10-15-16 REVISED.doc - Accepted Version

Download (102kB)
Item Type: Article
Uncontrolled Keywords: antimicrobial safety and tolerability, hematological malignancies, liposomal amphotericin B, pediatrics, pharmacokinetics
Depositing User: Symplectic Admin
Date Deposited: 23 Mar 2017 08:01
Last Modified: 16 Nov 2021 08:11
DOI: 10.1128/AAC.01477-16
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3006561